Inhibition of acalabrutinib metabolism by finerenone and its molecular docking studies.
Saved in:
| Title: | Inhibition of acalabrutinib metabolism by finerenone and its molecular docking studies. |
|---|---|
| Authors: | Wang P; The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.; Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Zhejiang, China., Fu H; The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.; Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Zhejiang, China., Wu J; The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China., Li R; The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China., Cao L; The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China., Xu RA; The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China. xra@wmu.edu.cn.; Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Zhejiang, China. xra@wmu.edu.cn., Lin W; The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China. linweihong@wmu.edu.cn. |
| Source: | Cell biology and toxicology [Cell Biol Toxicol] 2026 Feb 11; Vol. 42 (1). Date of Electronic Publication: 2026 Feb 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: Switzerland NLM ID: 8506639 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-6822 (Electronic) Linking ISSN: 07422091 NLM ISO Abbreviation: Cell Biol Toxicol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
